Aberin, Juliet L.

HRN: 21-53-59  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/28/2022
CEFUROXIME 1.5GM (VIAL)
08/29/2022
08/29/2022
IV
1.5g
LD
Preop Prophylaxis
Waiting Final Action 
08/29/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/29/2022
09/05/2022
IV
500
Q8
S/P CS Thickly Meconium Stained
Waiting Final Action 
08/30/2022
CEFUROXIME 500MG (TAB)
08/30/2022
09/06/2022
PO
500mg
Q12
S/P CS
Waiting Final Action 
08/30/2022
METRONIDAZOLE 500MG (TAB)
08/30/2022
09/06/2022
PO
500mg
Q8
S/P CS, Wound Dehiscence
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: